Latafor (Timolol Maleate, Latanoprost)

Latafor is prescribed for ocular conditions that require reduction of intra‑ocular pressure, primarily within the glaucoma and ocular hypertension therapeutic area.

• Open‑angle glaucoma: lowers intra‑ocular pressure to slow optic nerve damage.
• Ocular hypertension: reduces elevated eye pressure to prevent progression to glaucoma.
• Pseudoexfoliative glaucoma: helps control pressure in this secondary form of open‑angle glaucoma.

• Timolol maleate acts as a non‑selective beta‑adrenergic antagonist, blocking β1 and β2 receptors in the ciliary body to decrease aqueous humor production. Latanoprost is a prostaglandin F2α analog that binds to FP receptors in the iris‑ciliary body, remodeling extracellular matrix and enhancing uveoscleral outflow of aqueous humor. Through the combined actions, the net reduction of intra‑ocular pressure is achieved.

Latafor may cause ocular and systemic adverse reactions; reported events are categorized by frequency.

Common Side Effects

• Eye irritation or burning sensation: transient discomfort after instillation.
• Blurred vision: temporary visual disturbance.
• Conjunctival hyperemia: mild redness of the eye.
• Eyelash changes: increased length or thickness.

Serious or Rare Side Effects

• Severe allergic reaction: swelling, itching, or rash requiring medical attention.
• Persistent ocular inflammation: uveitis or iritis.
• Systemic bradycardia or hypotension: unusually low heart rate or blood pressure.

Before prescribing Latafor, clinicians should evaluate patient history and follow specific safety measures.

• Assess cardiovascular status: avoid use in patients with severe bradycardia or heart block.
• Monitor respiratory conditions: caution in asthma or COPD due to beta‑blocker effect.
• Evaluate ocular surface: discontinue if severe eye irritation or allergic response occurs.
• Check for hypersensitivity: avoid in individuals allergic to timolol, latanoprost, or any excipients.
• Use with caution in pregnancy: limited data, risk‑benefit assessment required.
• Store at room temperature: keep in original container, protect from light and moisture.

Latafor can interact with other medications; awareness of major and moderate interactions helps prevent adverse outcomes.

Major Interactions (Avoid)

• Non‑selective beta‑blockers (oral): additive systemic beta‑blockade may cause bradycardia.
• Sympathomimetic agents (e.g., epinephrine eye drops): antagonistic effect reducing efficacy.

Moderate Interactions (Monitor Closely)

• Carbonic anhydrase inhibitors: may enhance intra‑ocular pressure lowering effect.
• Anticholinergic eye drops: potential for reduced aqueous outflow.
• Systemic antihypertensives: monitor blood pressure for additive hypotensive effect.